—

Galenica Sante AG (GALE.SW) — the peer cohort

As of 2026-10-15 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Galenica Sante AG ranks 9 of 9 in its cohort on the Closelooknet composite (45/100) — the cohort is led by Halozyme Therapeutics Inc at 75/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALE.SW Galenica Sante AG 45 42 29 62 info 14.2%
YPSN.SW Ypsomed Holding AG 56 75 62 28 info 9.5%
BANB.SW Bachem Holding AG 51 85 40 32 ok 0%
TECN.SW Tecan Group AG 49 96 27 52 ok 3.6%
MOVE.SW Medacta Group SA 48 14 57 30 warn 34.4%
HALO Halozyme Therapeutics Inc 75 98 94 47 ok 0.7%
DXCM DexCom Inc 66 87 80 34 watch 9.8%
ARGX.BR Argen-X 64 64 75 28 info 18%
ONC BeiGene, Ltd. 64 84 63 30 ok 2.9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-15

Quick answers

Who are Galenica Sante AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Ypsomed Holding AG (YPSN.SW), Bachem Holding AG (BANB.SW), Tecan Group AG (TECN.SW), Medacta Group SA (MOVE.SW), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), Argen-X (ARGX.BR), BeiGene, Ltd. (ONC).

How does GALE.SW score against its peers?

Galenica Sante AG's composite reads 45/100, ranking 9 of 9 in its cohort as of 2026-10-15; the cohort's highest composite is Halozyme Therapeutics Inc at 75/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.